Filtered By:
Condition: Osteoarthritis
This page shows you your search results in order of date. This is page number 7.
Order by Relevance | Date
Total 352 results found since Jan 2013.
Indirubin relieves inflammatory injury of chondrocytes in a mouse model of osteoarthritis
CONCLUSION: Indirubin has a protective effect on osteoarthritis tissue and alleviates inflammation and damage of osteoarthritis chondrocytes possibly through NPAS2.PMID:36210712 | PMC:PMC9550548 | DOI:10.12122/j.issn.1673-4254.2022.09.15
Source: Journal of Southern Medical University - October 10, 2022 Category: Universities & Medical Training Authors: X Chen X Qi Y Cao Y Li H Li Q Wang J Ai Source Type: research
Stabilization of hypoxia-inducible factor-1 α alleviates osteoarthritis via interacting with Per2 and resetting the circadian clock
CONCLUSIONS: This study shows that circadian clock resetting caused by DMOG is at least partially mediated by the HIF1α through interaction with the Per2 promoter and proposes DMOG as supportive therapy for OA.PMID:36162153 | DOI:10.1016/j.tice.2022.101942
Source: Tissue and Cell - September 26, 2022 Category: Cytology Authors: Chenzhong Wang Yueqi Zhang Zhe Wang Wei Yu Minji Tong Zuoqin Yan Source Type: research
Chondroitin sulfate modified chitosan nanoparticles as an efficient and targeted gene delivery vehicle to chondrocytes
In conclusion, CH-CS nanoparticles can be considered as a candidate for gene therapy purposes in cartilage diseases.PMID:36049252 | DOI:10.1016/j.colsurfb.2022.112786
Source: Colloids and Surfaces - September 1, 2022 Category: Biotechnology Authors: Naghmeh Akbari Moghadam Fatemeh Bagheri Mohamadreza Baghaban Eslaminejad Source Type: research
Inhibition of GAB2 expression has a protective effect on osteoarthritis:An in vitro and in vivo study
In conclusion, our study demonstrates that GAB2 is a potential therapeutic target for OA.PMID:36007472 | DOI:10.1016/j.bbrc.2022.08.006
Source: Biochemical and Biophysical Research communications - August 25, 2022 Category: Biochemistry Authors: Haokun Mo Siying Yang An-Min Chen Source Type: research
Network Pharmacology-Based Strategy to Investigate the Mechanisms of < em > Cibotium barometz < /em > in Treating Osteoarthritis
Evid Based Complement Alternat Med. 2022 Jul 14;2022:1826299. doi: 10.1155/2022/1826299. eCollection 2022.ABSTRACTCibotium barometz is a representative tonifying kidney drug and is widely used for osteoarthritis (OA) in traditional Chinese medicine. However, its regulatory mechanisms in treating OA remain to be sufficiently investigated. The main chemical components of Cibotium barometz were screened through the TCMID database and the corresponding targets were acquired through SwissTargetPrediction. The OA-related targets were obtained from the OMIM, Genecards, Genebank, TTD, and DisGeNET databases. The prediction of key ...
Source: Evidence-based Complementary and Alternative Medicine - July 25, 2022 Category: Complementary Medicine Authors: Guang-Yao Chen Yi-Fei Wang Xin-Bo Yu Xiao-Yu Liu Jia-Qi Chen Jing Luo Qing-Wen Tao Source Type: research
